Agilent's New Metrology Option

Zacks

Agilent Technologies Inc (A) recently unveiled a metrology option for its PNA (Peptide Nucleic Acid) network analyzers. The newly-added option aims at offering national metrology institutes and calibration laboratories accurate S-parameter measurement. The offering is priced $84,130 onwards.

A network analyzer measures the network parameters of electrical networks. These days, network analyzers measure s-parameters (scattering parameters) as reflection and transmission of electrical networks can be measured easily at high frequencies rather than at low frequencies.

Metrology laboratories primarily look for stability and measurement in a network analyzer. However, majority of the available solutions failed to depict thermal stability. Agilent’s new solution is equipped with a technique that can characterize thermal stability of its network analyzers, independent of the effects from cables and adapters.

Metrology laboratories benefit from the enhanced performance of the PNA family, largely as a result of the new option, which addresses specific measurement needs.

According to a latest research report from TechNavio's analysts, the Global Liquid Analytical Instrument market is expected to grow at a CAGR of 6.39% over the period 2012-2016, driven by the growing need for better analysis. Agilent’s acquisitions, new products and testing systems will definitely help it to benefit from this growth.

Agilent Technologies is a broad-based original equipment manufacturer of test and measurement equipment. The company’s third-quarter revenues were down 4.6% sequentially and 4.1% year over year to $1.65 billion. However, earnings per share of 68 cents beat the Zacks Consensus Estimate by 6 cents or 9.6%, helped by solid cost management.

Currently, Agilent has a Zacks Rank #3 (Hold). Other stocks that look attractive this season are Microchip Technology Inc (MCHP) with a Zacks Rank #1 (Strong Buy), and Cognex Corp (CGNX) and NXP Semiconductors NV (NXPI), both with a Zacks Rank # 2 (Buy).
 

Read the Full Research Report on A
Read the Full Research Report on MCHP
Read the Full Research Report on CGNX
Read the Full Research Report on NXPI


Zacks Investment Research

Rates

View Comments (1)